HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...

首个专门针对清除潜伏HIV-1细胞的T细胞受体（TCR）疗法已经通过了初步临床试验。这种双特异性免疫疗法可以靶向并清除那些长期携带HIV的CD4+细胞，也就是所谓的“病毒储存库”。

Under Trump's foreign aid pause, all payments by U.S. Agency for International Development (USAID) stopped on Tuesday - for the first time since the fiscal year began on Oct. 1 - and have not resumed, ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...

A move by the Trump administration to freeze funding for PEPFAR, the widely heralded international HIV/AIDS program, is ...

today announced the opening of the ACACIA study (Antiretrovirals Combined with Antibodies for HIV-1 Cure in Africa), also ...

The US State Department has lifted the ban on HIV aid to SA and other low-income after President Donald Trump issued a ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...